L-Lactic acid produced by the anaerobic glycolytic pathway in contraction of skeletal muscles can be metabolized in the muscle itself. However, over-accumulation of L-lactic acid led to intracellular acidification and apoptosis. 1) L-Lactic acid transport is thought to play an important role in the regulation of L-lactic acid circulation into and out of muscle. Two factors may regulate the utilization of L-lactic acid in muscle: transport across the sarcommal membrane and the metabolic need of the muscle.
acid transport is thought to play an important role in the regulation of L-lactic acid circulation into and out of muscle. Two factors may regulate the utilization of L-lactic acid in muscle: transport across the sarcommal membrane and the metabolic need of the muscle. 2) In mammalian cells, it has been clearly demonstrated that L-lactic acid transport via a facilitated system occurs across the cell membrane. [3] [4] [5] On the other hand, specific H ϩ /monocarboxylate cotransport has been demonstrated in sarcolemmal vesicles from skeletal muscle. These studies showed that L-lactic acid was transported by a mechanism obeying Michaelis-Menten kinetics. [6] [7] [8] [9] However, it has not been demonstrated in detail whether monocarboxylate transporter (MCT) isoform concerned in the transport of L-lactic acid in skeletal muscle. Moreover, the effects of monocarboxylic acids and monocarboxylate drugs on the MCT-mediated transport of L-lactic acid have not been elucidated.
At present, there is some evidence that MCTs may play a role in the transport of some drugs such as valproic acid and statins, inducing adverse events including myopathy and rhabdmyolysis. [10] [11] [12] [13] [14] The human rhabdomyosarcoma (RD) cells, prototypic embryonal rhabdomyosarcoma cell line, is a tumor of skeletal muscle origin affecting children and young adults and expresses a number of muscle-specific proteins. 15) In terms of drug delivery to skeletal muscles, to clarify a role of MCT is possibility of leading to minimize the side effects and helps to understand about pharmacokinetic properties of drugs that have monocarboxylate structures within the molecules. To elucidate the transport mechanism of L-lactic acid in RD cells seems to clarify the physiological role of the MCT in skeletal muscles.
The aim of this study was to characterize L-lactic acid transport using an RD cell line as a model of in vitro skeletal muscle. It is important to obtain a better understanding of the transport mechanism of L-lactic acid in skeletal muscle. The effects of monocarboxylic acids and monocarboxylate drugs on the uptake and efflux of L-lactic acid in RD cells were investigated.
MATERIALS AND METHODS

Chemicals [
14 C] L-Lactic acid sodium salt was purchased from Amersham Life Science (Buckinghamshire, U.K.). LLactic acid sodium salt was purchased from ICN Biomedicals Inc. Pravastatin was kindly donated by Sankyo (Tokyo, Japan). All other reagents were of the highest grade available and used without further purification.
Cell Culture RD cells were routinely maintained in plastic culture flasks (Corning Incorporated Corning). These stock cells were subcultivated before reaching confluence. The culture medium consisted of Eagle's minimal essential medium (Sigma) supplemented MEM amino acids solution, MEM vitamin solution, 10% fetal bovine serum (ICN Biomedicals, Inc., Aurora, OH) and 1% penicillin-streptomycin. The RD cells were grown in an atmosphere of 5% CO 2 at 37°C. The standard medium was changed every 2 d. When the RD cells reached confluence, they were harvested with 0.25 mM trypsin and 0.2% EDTA (0.5-1 min at 37°C), resuspended and seeded into a new flask.
For the uptake and efflux studies, RD cells were seeded at a cell density of 1-2ϫ10 5 cells/ml on 24-well plastic plates (Corning Coster Corp., Cambridge, MA U.S.A.). The cell monolayers were fed a fresh growth medium every 2 d and were then used at 4 to 6 d for the uptake and efflux experiments.
RT-PCR Analysis Total RNA was prepared from RD cells using an RNeasy mini Kit and an RNase-Free DNase Set (QIAGEN). Single-strand cDNA was made from 2 mg total RNA by reverse transcription (RT) using an Omniscript RT Kit. PCR was performed using Hot Star Taq PCR (QIAGEN) with MCT1, 2, 4 and GAPDH specific primers through 40 cycles of 94°C for 30 s, 51°C for 1 min, and 72°C for 1 min. The primers specific to human MCT 1, 2, 4 and GAPDH were designed based on the GenBank TM database (accession no.: NM_003051, NM_004731, NM_004207 and NM_002046, respectively). The sequences of the specific primers were as follows: the sense sequence (1377-1396) was 5Ј-CCA TTG TGG AAT GCT GTC CT-3Ј and the antisense sequence (1897-1916) was 5Ј-CCT ACT TCT TTC CCC CAT CC-3Ј for human MCT1: the sense sequence (812-831) was 5Ј-GCC CAA AGA AAA TCA AAA CG-3Ј and the antisense sequence (1331-1351) was 5Ј-AAT CCA CCA ATT TAC CTG CAA-3Ј for human MCT2: the sense sequence (867-886) was 5Ј-ATC CTG GGC TTC ATT GAC AT-3Ј and the antisense sequence (1387-1406) was 5Ј-CTT CAG GAA ATG CTC CAC CT-3Ј for human MCT4 : the sense sequence (285-304) was 5Ј-TGG AAA TCC CAT CAC CAT CT-3Ј and the antisense sequence (806-825) was 5Ј-TTC TAG ACG GCA GGT CAG GT-3Ј for human GAPDH.
The PCR products were subjected to electrophoresis on a 1% agarose gel and then visualized by ethidium bromide staining.
Quantitative Real-Time PCR Quantitative real-time PCR was performed using an ABI PRISM 7700 sequence Detector (Applied Biosystems) with 2ϫSYBR Green PCR Master Mix (Applied Biosystems) as per the manufacturer's protocol. PCR was performed using MCT1-, MCT2-, MCT4-or GAPDH-specific primers through 50-60 cycles of 95°C for 15 s, 60°C for 1 min after pre-incubation at 95°C for 10 min. The primers specific to human MCT 1, 2, 4 and GAPDH were designed based on the GenBank TM database (accession no.: NM_003051, NM_004731, NM_004207 and NM_002046, respectively). The sequences of the specific primers were as follows: the sense sequence (1377-1396) was 5Ј-CCA TTG TGG AAT GCT GTC CT-3Ј and the antisense sequence (1454-1473) was 5Ј-CCA CAT GCC CAG TAT GTG TA-3Ј for human MCT1: the sense sequence (1250-1270) was 5Ј-TCG TGG GTG CAC CAA GAT TTT-3Ј and the antisense sequence (1331-1351) was 5Ј-AAT CCA CCA ATT TAC CTG CAA-3Ј for human MCT2: the sense sequence (867-886) was 5Ј-ATC CTG GGC TTC ATT GAC AT-3Ј and the antisense sequence (948-967) was 5Ј-ATG GAG AAG CTG AAG AGG TA-3Ј for human MCT4 : the sense sequence (730-749) was 5Ј-AAG GTC ATC CCT GAG CTG AA-3Ј and the antisense sequence (806-825) was 5Ј-TTC TAG ACG GCA GGT CAG GT-3Ј for human GAPDH.
Uptake Study After removal of the growth medium, cells were washed two times with HEPES (pH 7.4) buffer (25 mM D-glucose, 137 mM NaCl, 5.37 mM KCl, 0.3 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 4.17 mM NaHCO 3 , 1.26 mM CaCl 2 , 0.8 mM MgSO 4 and 10 mM HEPES) and preincubated at 37°C for 10 min with 0.5 ml of HEPES (pH 7.4) buffer. Uptake was initiated by applying 0.5 ml MES (pH 5.5-6.5) buffer (25 mM D-glucose, 137 mM NaCl, 5.37 mM KCl, 0.3 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 4.17 mM NaHCO 3 , 1.26 mM CaCl 2 , 0.8 mM MgSO 4 and 10 mM MES) or HEPES (pH 7.0-8.0) buffer containing [ 14 C] L-lactic acid (0.2 mCi/ml). The uptake study was performed at 37°C due to physiological temperature. After a predetermined time period, uptake was terminated by suctioning off the applied solution and immersing the plates in ice-cold HEPES (pH 7.4) buffer. And cells were washed two times with ice-cold HEPES (pH 7.4) buffer. The cells were then solubilized in 0.5 ml of 1% SDS/0.2 N NaOH. Samples (0.5 ml) was mixed with 8 ml of scintillation cocktail (ASC II, Amersham) to measure the radioactivity in a liquid scintillation counter (Packard, 1600TR). Protein concentration was measured by the method of Lowry et al. 16) with bovine serum albumin as a standard.
Efflux Study After removal of the growth medium, cells were preincubated at 37°C for 10 min with 0.5 ml of HEPES (pH 7.4) buffer. After removal of the medium, cells were incubated with 0.5 ml of MES (pH 6.0) buffer containing [ where V and S are uptake rate of L-lactic acid at 5 min and concentration of L-lactic acid, respectively.
Unless otherwise indicated, all data represent the meanϮ S.D. of the mean. Analysis of variance (ANOVA) and unpaired Student's t-test were used for statistical analysis, and a value of pϽ0.05 was considered significant.
RESULTS
RT-PCR Analysis of the MCT Family in RD Cells
In order to clarify the subtypes of MCT present in the RD cells, RT-PCR experiments were performed to determine MCT1, 2 and 4 in RD cells using total RNA isolated from RD cells and specific primers of human MCT1, 2 and 4. The mRNAs of MCT1, 2 and 4 were found to be expressed in RD cells (Fig. 1) .
Time 14 C] L-lactic acid uptake by RD cells involves pH-dependent uptake (Fig. 3) .
The following uptake experiments were performed at pH 6.0 to characterize the L-lactic acid transport mechanism because pH 6.0 closer to the physiological pH than pH 5.5. Figure 4 shows the concentration-dependent uptake of [ 14 The [uptake by 62.2% and 50.0%, respectively. Carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), a protonophore, at 0.05 mM also significantly inhibited [ 14 C] L-lactic acid uptake by 68.8%. In contrast, phthalic acid, dicarboxylicacid, and L-amino acids had no effect on [ 14 C] L-lactic acid efflux was determined by the amount remaining in RD cells. The efflux was significantly inhibited when the efflux medium was at acidic pH (pH 6.0). In contrast, when the efflux medium was at alkaline pH, the efflux was tended to enhance. Since the efflux of [ 14 C] L-lactic acid was linear for the initial 1 min, efflux over a period of 1 min was subsequently used for inhibition study.
Concentration Dependence of L-Lactic Acid Uptake by RD Cells
Effects of Several Inhibitory Conditions on Efflux of LLactic Acid from RD Cells
The efflux of L-lactic acid was significantly inhibited by CHC and phloretin and was also markedly inhibited by pravastatin (Table 3 ). In contrast, butyric acid, a substrate for MCT1, 17, 18) , respectively (Fig. 5) . Accordingly, MCT4 mRNA was found to be present markedly greater than that MCT2 in RD cells.
DISCUSSION
In the present study, it was found that L-lactic acid was taken up into RD cells via an H ϩ -coupled transport system. mRNAs of MCT1, MCT2 and MCT4 were expressed in RD cells. On the other hand, MCT3 was not expressed in RD cells (data not shown). L-lactic acid uptake took place in a pH-, temperature-and concentration-dependent manner. The corresponding K m and V max values are 1.19 mM and 16.9 nmol/mg protein/min, respectively. This K m value was comparable to its K m values for MCT1 or MCT2. 19) Accordingly, MCT1 or MCT2 is responsible for L-lactic acid uptake by RD cells. Quantitative real-time PCR analysis supported that MCT1 mRNA was found to be present markedly greater than that MCT2 in RD cells. This result is consistent with the result previously reported for which MCT1 is more abundant in muscles that have a high percentage of oxidative cells than in glycolytic muscles and thus has been suggested to play a major role in influx of L-lactic acid for oxidation. 20, 21) Therefore, MCT1 most probably acts on L-lactic acid uptake at RD cells as well as the skeletal muscle. The H ϩ -coupled L-lactic acid uptake by RD cells appears to be specific for monocarboxylic acids. The results suggest that the uptake of L-lactic acid was inhibited by monocarboxylic acids, including valproic acid, nicotinic acid and pravastatin, and that neither dicarboxylic acid nor amino acids had any effect on the uptake of L-lactic acid by RD cells.
On the other hand, the efflux of L-lactic acid from RD cells was decreased when the efflux medium was at acidic pH (pH 6.0). In contrast, when the efflux medium was at alkaline pH, the efflux was tended to enhance. Moreover, the efflux was inhibited by CHC and phloretin (typical MCT1, 2 and 4 inhibitors) and by pravastatin, monocarboxylate drug. These results suggest that MCT participates in the efflux of L-lactic acid from RD cells. However, butyric acid (a MCT1 substrate) had no effect on the efflux of L-lactic acid. Accordingly, MCT2 or MCT4 is responsible for L-lactic acid efflux by RD cells. Quantitative real-time PCR analysis supported that MCT4 mRNA was found to be present markedly greater than that MCT2 in RD cells. This result is consistent with the 1200
Vol. 28, No. 7 The amount of [ immunohistochemical characterization of MCT4, which is the major MCT isoform found in muscles, especially in white muscle fibers and is thought to play a primary role in the efflux of L-lactic acid from muscle fibers. 22, 23) Therefore, L-lactic acid efflux is mediated by MCT4 in RD cells as well as the skeletal muscle. We conclude that MCT1 is responsible for L-lactic acid uptake and L-lactic acid efflux is mediated by MCT4 in RD cells. Moreover, the uptake of L-lactic acid by RD cells was inhibited by monocarboxylate drugs, including valproic acid, nicotinic acid and pravastatin. These findings provide important information to obtain better understanding of the transport mechanism of L-lactic acid in skeletal muscle and drug delivery to the skeletal muscle.
